07/06/2016
https://congress.gov...
"It is obvious that companies have less incentive to stay in the United States than they did before these bills became law."
"This Administration has indicated that the increased tax will have little to no negative effect on medical innovation in the United States. That just begs credulity, Mr. Chairman."
"Put me down, as I said at the last hearing you had on this, as undecided on this particular bill."
"My basic problem is that I am not sure the FDA deserves a large increase in user fees given the amount of money that they have been receiving in general fund increases."